|
HORIZON-PFT: Pivotal Fracture Trial Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about HORIZON-PFT: Pivotal Fracture Trial conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. HORIZON-PFT: Pivotal Fracture Trial Clinical research trials and HORIZON-PFT: Pivotal Fracture Trial medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like HORIZON-PFT: Pivotal Fracture Trial. HORIZON-PFT: Pivotal Fracture Trial Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a HORIZON-PFT: Pivotal Fracture Trial clinical trial. Test subjects typically obtain the finest healthcare available for their HORIZON-PFT: Pivotal Fracture Trial condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > HORIZON-PFT: Pivotal Fracture Trial  HORIZON-PFT: Pivotal Fracture Trial
HORIZON-PFT: Pivotal Fracture Trial
For Condition: Osteoporosis
Status: No longer recruiting
Sponsor(s): Novartis Pharmaceuticals ,
Synopsis: HORIZON-PFT (Pivotal Fracture Trial) will study the effect of zoledronic acid, given once per year, on the treatment of osteoporosis in women past menopause. Hip and vertebral fractures are the most devastating consequences of osteoporosis. HORIZON-PFT is designed to determine the benefits of zoledronic acid in fracture reduction at both the hip and spine.
Details: The HORIZON-PFT study is currently underway in more than 200 centers in the United States, Canada, Europe, Asia Pacific and South America. It is our goal to recruit 7400 women with osteoporosis for this study. All study medications are provided to you free of charge including calcium and vitamin D supplements.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 65 Years/89 Years
Genders: Female
Protocol Entry Criteria: Inclusion Criteria: - Female, 65-89 years old - No history of severe liver, kidney or eye disease Exclusion Criteria: - Current bisphosphonate users such as Aredia® (pamidronate), Didronel® (etidronate), Fosamax® (alendronate), Actonel® (residronate), Skelid® (tiludronate) - Using hip protectors
Total Enrollment: 7400
Location and Contact Information:
McGuire Veterans Affairs Medical Center
Richmond, Virginia, 23249
United States
VA Commonwealth University
Richmond, Virginia, 23298
United States
University of Texas Health Center at Tyler -Center for Clinical Research
Tyler, Texas, 75708
United States
Longmont Medical Research Network
Longmont, Colorado, 80501
United States
Radiant
Wyomissing, Pennsylvania, 19610
United States
Northwestern University Center for Clinical Research
Chicago, Illinois, 60611
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261
United States
Radiant Research- San Diego
San Diego, California, 92108
United States
United Osteoporosis Centers (UOC)
Gainesville, Georgia, 30501
United States
Health Core
Newark, Delaware, 19713-2072
United States
Winthrop U Hospital
Mineola, New York, 11501
United States
Anchor Research Center
Naples, Florida, 34102
United States
Internal Medicine Associates
Fargo, North Dakota, 58104
United States
Sarasota Arthritis Center
Sarasota, Florida, 34239
United States
Einstein
Philadelphia, Pennsylvania, 19115
United States
Heartland Research Associates, LLC
Wichita, Kansas, 67207
United States
Sam Clinical Research Center
San Antonio, Texas, 78229
United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19131
United States
New Mexico Clinical Research and Osteoporosis Center, Inc
Albuquerque, New Mexico, 87106
United States
University of Alabama at Birmingham
Birmingham, Alabama, 35205
United States
Washington University School of Medicine
St. Louis, Missouri, 63110
United States
Osteoporosis Medical Center
Beverly Hills, California, 90211
United States
Palm Beach Research Center
West Palm Beach, Florida, 33409
United States
Medical Specialists
Munster, Indiana, 46321
United States
Diabetes Regional Research Center
Midland, Texas, 79705
United States
Colorado Center for Bone Research
Lakewood, Colorado, 80227
United States
Orthopaedic Hospital
Los Angeles, California, 90007
United States
Radiant
Stuart, Florida, 34996
United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115
United States
University of California Davis- Gen Med Research
Sacramento, California, 95817
United States
The Foundation for Osteoporosis Research and Education
Oakland, California, 94612
United States
The Physicians Clinic
Spokane, Washington, 99204
United States
Oregon Health and Science University
Portland, Oregon, 97201
United States
Mount Sinai School of Medicine
New York City, New York, 10029
United States
University of Arkansas for Medical Science
Little Rock, Arkansas, 72205
United States
University of Cincinnati Bone Health and Osteoporosis Center
Cincinnati, Ohio, 45219
United States
Clinical Pharmacology Study Groups
Worcester, Massachusetts, 01610
United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635
United States
Center for Arthritis and Osteoporosis
Elizabethtown, Kentucky, 42701
United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
United States
Rhode Island Hospital, Osteoporosis Research/ Bone Density Unit
Providence, Rhode Island, 02903
United States
Osteoporosis Prevention Center
San Diego, California, 92103
United States
Roger William Medical Center
Providence, Rhode Island, 02908
United States
Southern Arizona VA
Tucson, Arizona, 85723
United States
School of Medicine
Indianapolis, Indiana, 46202
United States
Osteoporosis Clinical Trial Center
Hagerstown, Maryland, 21740
United States
Hampton Roads Center for Clinical Research, Inc
Norfolk, Virginia, 23502
United States
Maine Center for Osteoporosis Research and Education
Bangor, Maine, 04401
United States
Avera Research Institute
Sioux Falls, South Dakota, 57105
United States
Endwell Family Physicians
Endwell, New York, 13760
United States
Osteoporosis Research Unit
Seattle, Washington, 98144
United States
Arthritis Regional Research Center
Mercerville, New Jersey, 08619
United States
Northeast Clinical Research
Hamden, Connecticut, 06518-3272
United States
Phoenix OB-GYN Associates, LLC
Moorestown, New Jersey, 08057
United States
Diablo Clinical Research, Inc
Walnut Creek, California, 94598
United States
CRA Research
Ft. Lauderdale, Florida, 33334
United States
West Cancer Clinic
Memphis, Tennessee, 38120
United States
University of Tennessee Health Science
Memphis, Tennessee, 38105
United States
Arizona Arthritis Research
Paradise Valley, Arizona, 85253
United States
Comprehensive Clinical Trials, LLC
West Palm Beach, Florida, 33409
United States
Additional Information:
Study ID Numbers: CZOL446H2301;
Study Start Date:
Record last reviewed: February 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00049829
Other Osteoporosis Studies:
1. Treatment of Childhood Osteoporosis with Alendronate (Fosamax)
2. CVD Risk and Health in Postmenopausal Phytoestrogen Users
3. Bone Estrogen Strength Training
4. Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
5. Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
Related Studies:
Other Osteoporosis Clinical Trials
Other Delaware Clinical Trials
Other Newark Clinical Trials
HORIZON-PFT: Pivotal Fracture Trial
|
|
|
|
|
|
|
|
